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Abstract
Background—Mitral regurgitation (MR) has been associated with adverse outcomes after
myocardial infarction (MI). Without structural valve disease, functional MR has been related to
left ventricular (LV) remodeling and geometric deformation of the mitral apparatus. The aims of
this study were to elucidate the mechanistic components of MR after high-risk MI and to identify
predictors of MR progression during follow-up.
Methods—The Valsartan in Acute Myocardial Infarction Echo substudy prospectively enrolled
610 patients with LV dysfunction, heart failure, or both after MI. MR at baseline, 1 month, and 20
months was quantified by mapping jet expansion in the left atrium in 341 patients with good-
quality echocardiograms. Indices of LV remodeling, left atrial size, and diastolic function and
parameters of mitral valve deformation, including tenting area, coaptation depth, anterior leaflet
concavity, annular diameters, and contractility, were assessed and related to baseline MR. The
progression of MR was further analyzed, and predictors of worsening among the baseline
characteristics were identified.
Results—Tenting area, coaptation depth, annular dilatation, and left atrial size were all
associated with the degree of baseline MR. Tenting area was the only significant and independent
predictor of worsening MR; a tenting area of 4 cm2 was a useful cutoff to identify worsening of
MR after MI and moderate to severe MR after 20 months.
Conclusions—Increased mitral tenting and larger mitral annular area are determinants of MR
degree at baseline, and tenting area is an independent predictor of progression of MR after MI.
Although LV remodeling itself contributes to ischemic MR, this influence is directly dependent on
alterations in mitral geometry.
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Mitral regurgitation (MR) is a powerful predictor of adverse prognosis after myocardial
infarction (MI) with increased risk for death and heart failure and provides incremental
prognostic information over conventional known clinical and echocardiographic predictors
of risk after MI.1–5 Moreover, progression of MR in the chronic phase after MI is associated
with an increased likelihood of cardiovascular morbidity.1 Although MR can be caused by
discrete papillary muscle disruption after MI, this occurs rarely.6 Rather, the majority of
cases of post-MI MR develop in the absence of structural mitral disease and are caused as a
result of apical and posterior papillary muscle (PPM) displacement with consequent mitral
valve tethering and incomplete valve closure due to the restriction of leaflet motion,
resulting in functional MR.7–9 In addition, dilatation and loss of contraction of the mitral
annulus contribute to increased valvular malcoaptation, therefore increasing the severity of
MR.10,11
To understand the mechanistic components and the echocardiographic determinants of
baseline MR as well as the progression of MR during follow-up after MI, we studied
patients enrolled in the Valsartan in Acute Myocardial Infarction (VALIANT) Echo
substudy. We hypothesized that the effects of left ventricular (LV) remodeling on mitral
geometry deformation are the dominant factors underlying the genesis of post-MI MR and
its evolution.
METHODS
Study Population
VALIANT was designed to test the efficacy and safety of long-term treatment with
valsartan, captopril, and their combination after acute MI (between 0.5 and 10 days
previously) complicated by clinical or radiologic signs of heart failure, evidence of LV
systolic dysfunction (ejection fraction [EF] ≤ 0.35 on echocardiography or contrast
angiography and ≤ 0.40 on radionuclide ventriculography), or both. The main criteria for
exclusion were a previous intolerance or contraindication to an angiotensin-converting
enzyme inhibitor or angiotensin-receptor blocker and another disease known to limit life
expectancy severely.12 A total of 14,703 patients were eligible for this study.
The VALIANT Echo substudy was designed prospectively to test the hypothesis that
valsartan, either alone or in combination with captopril, could attenuate progressive LV
enlargement or improve LV function to a greater extent than captopril alone. Entry criteria
were identical to those for the main VALIANT study. All the clinical sites participating in
the main VALIANT study were invited to enroll patients in the VALIANT Echo substudy.
From 94 clinical sites in 13 different countries, a total of 610 echocardiographic studies were
sent to the core laboratory at Brigham and Women’s Hospital, where they were reviewed for
quality.13 Baseline characteristics of patients enrolled in the VALIANT Echo substudy were
similar to those who were not, as previously reported.13 Patients with echocardiographic
images of insufficient quality, absence of color-flow Doppler images, or color-flow Doppler
images of insufficient quality were excluded from the VALIANT MR Echo cohort, and the
final population consisted of 496 patients. For 341 of these patients, it was possible to
prospectively evaluate the evolution of MR after 20 months. Of the others, 84 patients died,
and for 71 patients, the 20-month echocardiographic study was not available or had MR
color-flow Doppler images of insufficient quality.
Echocardiographic examinations were performed at a mean of 4.9 ± 2.5 days after MI
(before randomization), at 1 month, and at 20 months. The median follow-up time was 24.7
months. The majority of patients were hemodynamically stable at the time of the
echocardiographic assessment. Except for minor differences, the VALIANT MR Echo
cohort was similar to the overall VALIANT cohort.1 Patients provided informed consent for
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inclusion in the VALIANT Echo substudy, and the protocol was approved by the
appropriate institutional review boards.
Baseline Clinical Characteristics
The following baseline clinical characteristics were analyzed in the VALIANT MR Echo
cohort: age; race; gender; blood pressure; heart rate; body mass index; Killip class; history
of MI, hypertension, diabetes, heart failure, or smoking; anterior or inferior MI site; Q-wave
or non Q-wave MI type; reperfusion therapy with thrombolysis or primary percutaneous
transluminal coronary intervention; previous therapy with angiotensin-converting enzyme
inhibitors; and treatment with aspirin, β-blockers, or statins at randomization.1,13
Echocardiographic Analysis
All echocardiographic studies were analyzed in the core laboratory at Brigham and
Women’s Hospital. Echocardiograms from videotape were digitized, and analyses were
performed with the use of quantitative analysis software.
LV endocardial borders were manually traced at end-diastole and end-systole in apical four-
chamber and two-chamber views. LV volumes and EF were derived according to the
modified biplane Simpson’s method.13,14 The LV sphericity indices were calculated as the
ratio of LV volumes (end-diastolic and end-systolic) and the volume of a sphere with a
diameter equal to the LV (end-diastolic and end-systolic) long axis (sphericity index = 6V/
πL3).14 LV volumes and sphericity indices were considered parameters of global LV
remodeling.
MR was assessed using a semiquantitative method tracing the area of the maximum systolic
jet expansion in the left atrium in four-chamber and two-chamber views. Left atrial (LA)
area was also measured in the same frame with the maximum regurgitant jet. According to
current guidelines, color-flow Doppler images of regurgitant jet were acquired using a
Nyquist limit (aliasing velocity) of 50 to 60 cm/sec and a color gain that just eliminated
random color speckle from nonmoving regions. All the color-flow Doppler images used the
same color map (red for flow toward the transducer and blue for flow away from the
transducer, with the shade of color indicating velocity up to the Nyquist limit). The MR jet
comprised a mosaic of many colors indicating turbulence. The protocol specified that the
same ultrasound instruments, transducers, and settings of the baseline acquisition should be
used for the follow-up examinations.
MR was then categorized by calculating MR jet/LA area ratio. MR was considered mild
when the regurgitant jet area occupied >5% and <20% of LA area, moderate when
regurgitant jet area occupied >20% and <40% of LA area, and severe when regurgitant jet
area occupied >40% of LA area.1,15,16 The presence of an eccentric jet raised the grade of
MR by one degree on the basis of evidence of reduced color-flow jet areas due to a loss of
momentum in jets adjacent to chamber walls.17,18 An eccentric jet was defined as a
regurgitant jet, which impinges on the LA wall immediately beyond the mitral valve.
The following indices of geometric mitral valve deformation were measured from
parasternal long-axis view (Figure 1): tenting area, defined as the area enclosed between the
annular plane and the mitral leaflets in mid-systole; coaptation depth, defined as the distance
between leaflet coaptation and the mitral annular (MA) plane in mid-systole7–9; anterior
mitral leaflet (AML) shape, visually assessed as concave or convex configuration of the
leaflet toward the left atrium in mid-systole (with convexity representing the normal
condition and concavity an expression of tethering of mitral valve leaflets)19; and AML
diastolic restricted motion, defined as maximal opening angle between the AML and the
annulus equal or inferior to the angle between the annulus and a line connecting the PPM
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head and intervalvular fibrosa.20 Moreover, maximum and minimum MA diameters were
measured in four-chamber and two-chamber views at end-diastole and end-systole, and MA
areas were calculated using an ellipsoid assumption (MA area = d1 × d2 × π/4); MA
contraction was calculated as the ratio of the difference between MA end-diastolic area and
MA end-systolic area to MA end-diastolic area.1,8,21
Outward displacement of the PPM, an index of global and local LV remodeling, was
quantified by annular-papillary distance, defined as the distance between the PPM head and
intervalvular fibrosa in the parasternal long-axis view in systole.8 Local remodeling of the
LV wall at the PPM attachment was evaluated by the presence of thinning or bulging of
inferior wall.22
LA volume was measured by the biplane area-length method from apical four-chamber and
two-chamber views at end-systole, and LA volume was indexed to body surface area.23
Diastolic function was evaluated by transmitral pulsed-wave Doppler from the apical four-
chamber view, and a restrictive pattern was defined as E/A peak wave ratio > 2 and
deceleration time < 140 msec.24 All the echocardiographic measurements were repeated in
three separate cardiac cycles.
Statistical Analysis
Baseline continuous data are expressed as mean ± SD, and categorical variables are
expressed as absolute numbers of patients and percentages. At baseline, patients were
divided into three groups according to MR degree (none, mild, and moderate to severe), and
a nonparametric test derived from Wilcoxon’s rank-sum test was used to examine trends in
baseline clinical and echocardiographic characteristics. During 20 months of follow-up, the
patients were divided into a group with no MR changes or improvement and a group with
MR increase of at least one grade; clinical and echocardiographic characteristics in these
two groups were compared using t tests for continuous variables and χ2 tests for discrete
variables. Backward and forward stepwise multivariate linear regression analysis was
performed to assess the baseline predictors of baseline MR jet/LA area ratio and the overall
change in MR jet/LA area ratio, using two different models. The first model considered only
echocardiographic variables, while the second one added the clinical variables that were
significant by univariate analyses to echocardiographic variables. The relationship between
baseline tenting area and MR severity at baseline and after 20 months was tested using a
logistic regression. The cutoff value of tenting area that was most sensitive and specific in
predicting MR was determined by means of receiver operating characteristic curve analysis.
Change in MR jet/LA area was compared with changes in LV and LA remodeling over time
using Pearson’s correlations.
Intraobserver reproducibility was tested in 15% of patients randomly selected, in a blinded
fashion. The mean differences and the SD of the differences between measurements were
calculated (Bland-Altman method), and variability was calculated as the SD of the
difference divided by the mean measurement.13 The overall coefficients of variability of the
continuous echocardiographic parameters were as follows: MR area, 1%; LA volume index,
5.4%; LV end-diastolic volume, 8.3%; diastolic sphericity index, 6.2%; annular-papillary
distance, 7.2%; tenting area, 6%; coaptation depth, 6.4%; and MA diastolic area, 5.5%. All
P values were two sided; P values < .05 were considered statistically significant. All
statistical analyses were performed using Stata version 8 (StataCorp LP, College Station,
TX).
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RESULTS
Baseline MR
Among the 496 patients with baseline echocardiographic evaluations of MR, 231 patients
(46%) did not have MR, 202 patients (41%) had mild MR, and 63 patients (13%) had
moderate to severe MR. MR severity at baseline was associated with older age (P < .001),
female sex (P < .001), prior MI (P < .01), hypertension (P = .02), diabetes (P < .01), heart
failure (P = .001), and non-Q-wave MI (P = .01).1
Echocardiographic measures of ventricular and mitral geometry associated with MR degree
are shown in Table 1. Patients with higher MR degrees had worse LV global remodeling,
with higher LV volumes and sphericity indices and lower EFs1; moreover, they had greater
annular-papillary distances and were more likely to have worse local remodeling of the
inferior wall. MR severity was also associated with increased geometric deformation of the
mitral apparatus (higher tenting area, coaptation depth, and MA areas with lower MA
contraction; presence of diastolic restricted motion and concavity of the AML). Higher MR
degree was associated with larger left atria and restrictive filling. Twenty-five patients
presented at baseline with eccentric jets. Considering only the 471 patients (95%) with
central jets, all the considered echocardiographic parameters were still significant
determinants of higher MR degree, with the exception of a restrictive diastolic pattern and
restrictive motion of the mitral leaflet.
In a multivariate model adjusted for echocardiographic variables, the degree of baseline MR
was related to parameters of altered mitral valve geometry (tenting area, P = .009; coaptation
depth, P = .046; MA diastolic area, P < .001) and larger left atria (P = .016); LV remodeling
indices were not independently associated with baseline MR degree. By adding to the
previous multivariate model the clinical variables that were significant by univariate
analyses, tenting area, coaptation depth, MA diastolic area, and LA volume index remained
independently associated with degree of baseline MR severity (P = .006, P = .011, P < .001,
and P = .013, respectively), while female sex was the only clinical factor independently
associated with MR degree (P = .006).
MR Progression
In 341 patients with completed echocardiographic follow-up, MR worsened by one degree
in 78 patients (23%) and by two degrees in 10 patients (3%) at 20 months compared with
baseline. Forty-seven patients (14%) experienced improvements in MR by one degree, and
in 206 patients (60%), the presence and severity of MR were unchanged. At 20 months, 150
patients (44%) had no detectable MR, 139 patients (41%) had mild MR, and 52 patients
(15%) had moderate to severe MR.
During the first month after MI, early MR progression was significantly greater than late
progression during the remaining follow-up period (1.9 ± 0.3% vs 0.4 ± 0.3% increase in
MR jet/LA area ratio during the first month and between 1 and 20 months, respectively, P
< .001). Patients with worsening by one or more MR degrees during the first month after MI
experienced the greatest increase in MR jet/LA area ratio during follow-up (11.4 ± 9.3% vs
0.01 ± 6.7%, P < .001) and were more likely to have moderate or greater MR degrees at 20
months (69% vs 31%, P < .001).
Among the clinical baseline characteristics, only systolic blood pressure was significantly
increased in the group of patients who developed worsening in MR degree after 20 months
(124 ± 15 vs 119 ± 14 mm Hg, P = .011). There was no difference in degree of MR
worsening by treatment group.
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Echocardiographic baseline characteristics according to worsening versus unchanged or
improved MR degree after 20 months are shown in Table 2. Greater baseline tenting area
and coaptation depth predicted MR progression in univariate analyses. Tenting area
remained a predictor of MR progression in multivariate analyses, in models including either
echocardiographic measures or a combination of echocardiographic and clinical variables (P
= .023). Adding 1-month MR data to this model, both tenting area and worsening by at least
one degree during the early phase after MI were significant and independent predictors (P
= .018 and P < .001, respectively). Sixteen of these patients presented with eccentric jets.
Considering only the 325 patients (95%) with central jets, tenting area and coaptation depth
were confirmed to be predictors of worsening MR.
LV and LA remodeling during the overall follow-up are shown in Table 3. MR worsening
was significantly correlated with the increases in LV and LA volumes and with the
reduction in LV function, although these correlations were weak.
Tenting Area as a Predictor of MR Severity and Worsening
Each 1-cm2 increase in tenting area was associated with greater MR not only at baseline but
also at 1 and 20 months (Figure 2). Receiver operating characteristic curve analysis
demonstrated that a tenting area of 4 cm2 was the optimal cutoff in predicting MR severity
(Figure 3). For each 1-cm2 increase in tenting area beyond 4 cm2, the odds ratio of
worsening MR degree during follow-up was 3.60 (95% confidence interval, 1.68–7.73), and
the odds ratio of having moderate or greater MR at 20 months was 5.79 (95% confidence
interval, 2.70–12.39) (Figure 4).
Discussion
We demonstrated that alterations in mitral geometry, indicated by mitral tenting, coaptation
depth, and diastolic MA area, as well as LA size, were associated with degree of baseline
MR after a high-risk MI. LV volume, sphericity and EF—expressions of global LV
remodeling—were associated with baseline MR in univariate analyses only and were not
independently related to the degree of MR in the early post-MI period or the progression of
MR over time. In contrast, baseline tenting area remained an independent predictor of
worsening MR over time. Therefore, mitral tenting, as a potential expression of localized
remodeling affecting mitral valve apparatus, seems to be superior to the classical indices of
global LV remodeling, both as determinant of baseline MR and as a predictor of MR
progression.
Our results are consistent with recent studies demonstrating the central role of mitral
geometric deformation in the genesis of ischemic MR7–9 and potentially provide new
insights regarding echocardiographic predictors of ischemic MR evolution. The main
novelty of this study is the demonstration that mitral tenting has a predictive value in
identifying patients with ischemic MR in whom progression is more likely to occur during
follow-up.
Functional MR, defined as abnormal mitral valve function in the absence of structural
abnormalities of the mitral apparatus, is commonly observed after MI and is an independent
predictor of mortality and cardiovascular morbidity.1–5,25,26 In normal hearts, papillary
muscles are parallel to the LV long axis and perpendicular to the leaflets and can balance
forces generated by ventricular pressure on the leaflet surface. Distortion of ventricular
geometry caused by infarction displaces the papillary muscles toward the apex and the
posterolateral wall, which results in a disadvantageous alignment of the papillary muscle
apparatus relative to the mitral leaflets. Consequently, mitral leaflets are drawn and tethered
into the ventricle and their motion is restricted from closure. Moreover, worse LV systolic
Meris et al. Page 6
J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 May 01.
$watermark-text
$watermark-text
$watermark-text
function and annular contraction contribute to decrease mitral valve closing forces and
increase valvular malcoaptation.7,11,27
We and others have previously shown that after high-risk MI, baseline MR is associated
with worse LV function, greater LV enlargement and chamber distortion, and worse MA
contraction.1,11 Global contractile dysfunction leads to functional MR only in presence of a
dilated left ventricle.28 Previous studies have indicated that increased sphericity in dilated
left ventricles could result in displaced papillary muscles, leading to MR.29 However, recent
studies have raised the question of whether global LV remodeling represents the main
determinant of post-MI MR, because similar degrees of LV dysfunction or enlargement are
associated with widely different degrees of MR.8,30 Indeed, localized remodeling of the
posterior walls leads to papillary muscle displacement and results in increased mitral tenting
independently of LV volumes.8 Moreover, varying degrees of leaflet adaptation to LV
remodeling may play a role in the development of functional MR.9,31
This study provides further confirmation of the central role of mitral geometric deformation
in the genesis of ischemic MR at baseline. These new results highlight the importance of
geometric changes of the mitral apparatus in the pathophysiology of post-MI MR. Indeed,
we found that increased mitral tenting, coaptation depth, and MA area seem to be the main
determinants of ischemic MR. Even if LV dysfunction, enlargement, and altered shape are
determinants of MR, they lose their predictive power in the multivariate analyses adjusted
for parameters of mitral geometry. Although geometric changes of the mitral apparatus are
related to LV enlargement and dysfunction, these appear to lead to excess valvular tenting
independently of global LV remodeling.
These results are consistent with the notion that mitral competence depends on the balance
of different forces acting on mitral leaflets, including tethering forces generated by papillary
muscle displacement, annular forces, and left ventricle–generated closing forces.7,23 The
final common pathway of all these forces may be the mitral tenting determining the level of
leaflet coaptation. Tethering forces acting on mitral leaflets lead to insufficient systolic
leaflet body displacement toward the annulus, with coaptation limited to leaflet tips31 and
consequent increase of the mitral tenting area. Annular dilatation has an adjunctive role in
inadequate mitral coaptation. When the leaflet bodies can reach the annular level in systole,
considerable annular dilatation would be required to result in inadequate mitral co-aptation,
because the ratio of leaflets to the annular surface area is >2.32 However, enlarged MA area
further increases the insufficiency of leaflet coaptation in the presence of augmented
tethering. LV dilatation and function are important determinants of baseline MR after MI as
well. Indeed, in a malfunctioning left ventricle, closing forces are unable to oppose
tethering, and global LV remodeling influences mitral geometry.
Most prior studies have focused on MR in the early phase after MI; in the present study, we
had the advantage of being able to follow patients and changes in MR over 20 months after
MI. In multivariate analyses, altered mitral geometry expressed by tenting area was the only
independent predictor of worsening regurgitation. Global LV dysfunction, dimensions, and
sphericity were not direct predictors of changes in ischemic MR during long-term follow-up.
These data suggest a central role for mitral geometric alteration on MR progression and that
mitral tenting area in particular was the crucial determinant of not just early post-MI MR but
of progression of MR over time. A comprehensive assessment of MR severity, mitral
geometry, and LV local and global remodeling in the acute phase after MI and during the
following months may improve patient risk stratification and might help identify patients
who might best benefit from particular types of surgical approaches to functional MR.33
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Some limitations of this study should be noted. MR degree was evaluated with a
semiquantitative method, mapping regurgitant jet expansion within the left atrium by color
flow Doppler. More rigorous quantitative methods such as proximal isovelocity surface area
and effective regurgitant orifice area are more challenging and less likely to be possible in
international, multicenter clinical trials such as VALIANT.1 Nevertheless, the mitral jet
area/LA area ratio has been shown to be well correlated with quantitative methods to
evaluate MR and to be a highly sensitive technique to detect even mild degrees of ischemic
MR.33
Our analysis is subject to survivor bias, as many patients with worse degrees of MR and
greater LV remodeling at baseline did not survive to undergo 20-month echocardiographic
assessments.1,13 Therefore, the severity of MR progression may be underestimated because
of patient dropout.
Mitral valve surgery was not a prespecified outcome in VALIANT, and data on this were
not collected. However, only 10 patients in the VALIANT Echo cohort underwent
subsequent cardiac surgery, suggesting that the number of patients who might have had
mitral valve surgery is likely to be very low.23
Finally, the tenting area cutoff of 4 cm2 obtained from a receiver operating characteristic
curve analysis has not been prospectively tested in an independent second population.
CONCLUSIONS
Alteration in mitral geometry, expressed by an increased tenting and dilated mitral annulus,
is an independent predictor of baseline MR after high-risk MI, while tenting area also
predicts worsening in MR during the following period. These data suggest that increased
mitral tenting is the final pathway by which LV remodeling alters mitral geometry and thus
influences the extent of regurgitation.
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Figure 1.
Indices of geometric mitral valve deformation and LV remodeling. (A) Tenting area (red
triangle), coaptation depth (blue line), MA diameter (basis of the red triangle), and annular-
papillary distance (yellow line). (B) Bulging of inferior wall (orange line). The PPM
attachment was outwardly displaced because of bulging of the inferior wall after necrosis.
(C) Convexity of the AML toward the left atrium in mid-systole (pink star). (D) AML
diastolic normal motion. The AML (pink line) in diastole moves forward the green line
connecting PPM head and intervalvular fibrosa.
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Figure 2.
Relationship between MR severity at baseline and after 1 and 20 months and each 1-cm2
increase in baseline tenting area.
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Figure 3.
Receiver operating characteristic (ROC) curve analysis showing the tenting area cutoff level
distinguishing worsening MR of at least one degree from unchanged or improved MR
during follow-up (A, red line) and moderate to severe MR from none to mild MR at 20
months (B, blue line).
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Figure 4.
(A) A patient with mild MR at baseline and a tenting area of 3.7 cm2 who experienced no
MR progression during follow-up. (B) A patient with mild MR at baseline and a tenting area
of 4.5 cm2 who worsened to moderate MR at 20 months.
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Table 1
Echocardiographic characteristics according to baseline MR degree (n = 496)
Variable
Baseline MR degree
P for trend
None or trace (n = 231
[46%]) Mild (n = 202 [41%])
Moderate to severe (n = 63
[13%])
LV remodeling
 LV EDV (mL) 112 ± 28 123 ± 29 139 ± 43 <.001
 LV ESV (mL) 67 ± 20 77 ± 23 88 ± 33 <.001
 LV EF (%) 40 ± 5 38 ± 6 38 ± 7 .001
 Sphericity index (%)
  Diastolic 42 ± 10 47 ± 10 50 ± 10 <.001
  Systolic 36 ± 10 40 ± 11 43 ± 9 <.001
 Annular-papillary distance (cm) 3.8 ± 0.6 4.1 ± 0.6 4.1 ± 0.5 .028
 Thinning-bulging of inferior wall 15% 24% 29% .011
Mitral valve geometry
 Tenting area (cm2) 3.8 ± 0.7 4.2 ± 0.7 4.1 ± 0.8 <.001
 Coaptation depth (cm) 1.5 ± 0.2 1.6 ± 0.2 1.6 ± 0.2 .008
 Mitral annulus
  Diastolic area (cm2) 7.1 ± 1 8.2 ± 1.2 9.6 ± 1.4 <.001
  Systolic area (cm2) 5.5 ± 0.9 6.5 ± 1.2 7.7 ± 1.4 <.001
  Annular contraction (%) 22 ± 6 21 ± 6 20 ± 6 .004
 Concavity of AML 31% 35% 56% .003
 Diastolic restricted motion 14% 19% 36% .003
Diastolic function and left atrium
 Restrictive pattern 9% 15% 21% .013
 LA volume index (mL/m2) 20 ± 5 26 ± 7 35 ± 10 <.001
EDV, End-diastolic volume; ESV, end-systolic volume.
Data are expressed as mean ± SD or as percentages.
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Table 2
Echocardiographic characteristics according to worsening MR
Variable
Overall population (n =
341)
No MR changes or
improvement (n = 253 [74%])
Worsening MR of at least
one grade (n = 88 [26%]) P
LV remodeling
 LV EDV (mL) 118 ± 30 118 ± 32 117 ± 26 .740
 LV ESV (mL) 72 ± 24 72 ± 25 71 ± 20 .592
 LV EF (%) 39 ± 6 39 ± 6 39 ± 6 .684
 Sphericity index (%)
  Diastolic 44 ± 11 44 ± 10 45 ± 11 .748
  Systolic 38 ± 11 37 ± 10 39 ± 13 .l28
 Annular-papillary distance (cm) 3.9 ± 0.6 3.8 ± 0.5 4.0 ± 0.6 .101
 Thinning-bulging of inferior wall 18% 19% 16% .331
Mitral valve geometry
 Tenting area (cm2) 3.9 ± 0.6 3.8 ± 0.6 4.2 ± 0.7 <.001
 Coaptation depth (cm) 1.6 ± 0.2 1.5 ± 0.2 1.6 ± 0.2 .032
 Mitral annulus
  Diastolic area (cm2) 7.8 ± 1.3 7.8 ± 1.3 7.7 ± 1.1 .448
  Systolic area (cm2) 6.1 ± 1.2 6.1 ± 1.3 6.0 ± 1.1 .283
  Annular contraction (%) 22 ± 6 22 ± 6 22 ± 6 .275
 Concavity of AML 35% 35% 37% .795
 Diastolic restricted motion 18% 17% 21% .459
Diastolic function and left atrium
 Restrictive pattern 13% 14% 9% .250
 LA volume index (mL/m2) 23 ± 7 23 ± 8 22 ± 7 .180
EDV, End-diastolic volume; ESV, end-systolic volume.
Data are expressed as mean ± SD or as percentages.
J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 May 01.
$watermark-text
$watermark-text
$watermark-text
Meris et al. Page 17
Table 3
Correlation between changes in MR jet/LA area ratio and LV and LA remodeling during 20 month follow-up
Variable Baseline 20 months Coefficient of correlation P
LV EDV (mL) 119 ± 32 120 ± 30 0.12 .027
LV ESV (mL) 73 ± 24 72 ± 25 0.15 .005
LV EF (%) 39 ± 6 41 ± 7 −0.11 .035
Sphericity index (%)
 Diastolic 45 ± 11 50 ± 11 0.097 .078
 Systolic 38 ± 11 44 ± 11 0.095 .084
LA volume index (mL/m2) 24 ± 8 26 ± 9 0.49 <.001
EDV, End-diastolic volume; ESV, end-systolic volume.
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